Elke Tatjana Prada

Elke Tatjana Aristizabal Prada

UNVERIFIED PROFILE

Are you Elke Tatjana Aristizabal Prada?   Register this Author

Register author
Elke Tatjana Prada

Elke Tatjana Aristizabal Prada

Publications by authors named "Elke Tatjana Aristizabal Prada"

12Publications

283Reads

46Profile Views

1PubMed Central Citations

Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.

Hypertension 2019 10 26;74(4):809-816. Epub 2019 Aug 26.

From the Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Germany (Y.Y., D.J., E.T.A.P., L.S.M., H.S., F.B., M.R., T.A.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739168PMC
October 2019

The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro.

Neuroendocrinology 2018 23;106(1):58-73. Epub 2017 Feb 23.

Department of Internal Medicine II, Campus Grosshadern, University Hospital, Ludwig-Maximilians University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000463386DOI Listing
January 2019

The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.

Endocr Relat Cancer 2018 10 12;25(10):893-908. Epub 2018 Jun 12.

Medizinische Klinik und Poliklinik IVInterdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), Klinikum der Universität München (KUM), Ludwig-Maximilians-University, Munich, Germany

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/view/journals/erc/25/10/ERC-1
Publisher Site
http://dx.doi.org/10.1530/ERC-18-0159DOI Listing
October 2018

Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.

Endocr Relat Cancer 2018 05 21;25(5):547-560. Epub 2018 Mar 21.

Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Campus Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0201DOI Listing
May 2018

Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.

Int J Mol Sci 2018 Apr 9;19(4). Epub 2018 Apr 9.

Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19041124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979346PMC
April 2018

Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism.

Hypertension 2017 11 3;70(5):875-881. Epub 2017 Oct 3.

From the Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität München, Germany (E.T.A.P., M.R., T.A.W.); and Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Italy (J.B., T.A.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10111DOI Listing
November 2017

The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.

PLoS One 2017 25;12(5):e0178375. Epub 2017 May 25.

Department of Internal Medicine II, Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System (GEPNET-KUM), University-Hospital, Ludwig-Maximilians-University of Munich, Bavaria, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178375PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444855PMC
September 2017